139 related articles for article (PubMed ID: 11786967)
41. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.
Lovell MO; Speeg KV; Havranek RD; Sharkey FE
Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888
[TBL] [Abstract][Full Text] [Related]
42. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
[TBL] [Abstract][Full Text] [Related]
43. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome.
Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N
Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508
[TBL] [Abstract][Full Text] [Related]
44. Is exfoliative bile cytology useful in the diagnosis of graft complications in liver transplantation?
Carrasco L; Sánchez-Bueno F; Sola J; Acosta F; Ramirez P; Robles R; Flores B; Parrilla P
Transplant Proc; 1995 Aug; 27(4):2281-2. PubMed ID: 7652806
[No Abstract] [Full Text] [Related]
45. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
[TBL] [Abstract][Full Text] [Related]
46. Pathogenesis and treatment of bile duct loss after liver transplantation.
Inomata Y; Tanaka K
J Hepatobiliary Pancreat Surg; 2001; 8(4):316-22. PubMed ID: 11521176
[TBL] [Abstract][Full Text] [Related]
47. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance.
Kemnitz J; Gubernatis G; Bunzendahl H; Ringe B; Pichlmayr R; Georgii A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2208-10. PubMed ID: 2652712
[No Abstract] [Full Text] [Related]
48. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
49. Transplantation pathology.
Hübscher SG
Semin Liver Dis; 2009 Feb; 29(1):74-90. PubMed ID: 19235661
[TBL] [Abstract][Full Text] [Related]
50. Reversibility from delayed hyperacute rejection in ABO-incompatible renal transplantation: histopathological findings of renal allograft biopsy.
Sugiyama K; Arai K; Aikawa A; Miyagi M; Ohara T; Hasegawa A; Muramatsu M; Hirayama N; Tajima E; Kawamura T; Ogihara H; Hadano T; Nakano H
Transplant Proc; 2005 Mar; 37(2):701-4. PubMed ID: 15848507
[TBL] [Abstract][Full Text] [Related]
51. Endotheliitis-like changes in chronic hepatitis C.
Lory J; Zimmermann A
Histol Histopathol; 1997 Apr; 12(2):359-66. PubMed ID: 9151124
[TBL] [Abstract][Full Text] [Related]
52. Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction.
Miyagi M; Ishikawa Y; Mizuiri S; Aikawa A; Ohara T; Hasegawa A
Clin Transplant; 2005 Aug; 19(4):456-65. PubMed ID: 16008588
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis.
Krishna M; Keaveny AP; Genco PV; Rosser BG; Dickson RC; Nguyen JH; Steers JL; Nakhleh RE
Transplant Proc; 2005 Jun; 37(5):2221-3. PubMed ID: 15964383
[TBL] [Abstract][Full Text] [Related]
54. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D
Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142
[TBL] [Abstract][Full Text] [Related]
55. Liver allograft pathology and biopsy interpretation.
Portmann B
Verh Dtsch Ges Pathol; 2004; 88():29-38. PubMed ID: 16892531
[TBL] [Abstract][Full Text] [Related]
56. Toll-like receptor expression in patients with renal allograft dysfunction.
Kwon J; Park J; Lee D; Kim YS; Jeong HJ
Transplant Proc; 2008 Dec; 40(10):3479-80. PubMed ID: 19100417
[TBL] [Abstract][Full Text] [Related]
57. Borderline changes in the Banff schema: rejection or no rejection?
Gaber LW
Transplant Proc; 2004 Apr; 36(3):755-7. PubMed ID: 15110652
[TBL] [Abstract][Full Text] [Related]
58. Banff schema for grading liver allograft rejection: an international consensus document.
Hepatology; 1997 Mar; 25(3):658-63. PubMed ID: 9049215
[TBL] [Abstract][Full Text] [Related]
59. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
60. Hepatocyte cytokeratin 7 expression in chronic allograft rejection.
Bellizzi AM; LeGallo RD; Boyd JC; Iezzoni JC
Am J Clin Pathol; 2011 Feb; 135(2):238-44. PubMed ID: 21228364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
